Stem cell therapies advance in Parkinson’s disease and beyond
During the height of New York City’s COVID-19 lockdown, a small group of people with Parkinson’s disease arrived at Memorial Sloan Kettering Cancer Center for an experimental neurosurgical procedure: the implantation of dopamine-producing neurons grown from human embryonic stem cells. Now, the researchers behind the trial have published results from that phase 1 study, showing […]
